HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Kaposi's sarcoma (clinical) — Clinical Guidelines

Overview

Kaposi's sarcoma (KS) is a low-grade vascular tumor associated with human herpesvirus 8 (HHV-8), often exacerbated by immunosuppression, including HIV infection and organ transplantation 1 7. It typically presents as skin lesions but can involve mucous membranes and internal organs, presenting variably across different patient populations.

Diagnosis

Clinical Presentation: Characteristic skin lesions (patches, plaques, nodules) often on lower extremities 1 5.

Histopathology: Essential for confirming diagnosis, assessing disease stage (patch, plaque, nodular) 1.

Imaging: Useful for assessing extent and visceral involvement, particularly in advanced cases 5.

Biopsy: Lymph node or other affected tissue biopsy may be necessary for definitive diagnosis and staging 5.

Management

First-Line Treatments:

- Chemotherapy: Vinblastine (IV) for disseminated disease 4. - Radiation Therapy: Effective for localized cutaneous lesions, particularly in AIDS-related KS 6.

Adjunctive Treatments:

- Immunomodulatory Agents: Consider in immunocompromised patients, tailored to underlying condition 1 4. - Supportive Care: Pain management, wound care, and addressing complications like airway obstruction 2 3.

Special Populations

Immunocompromised Patients: Higher risk, especially post-transplant and HIV-positive individuals 1 5 7.

Pediatrics: Can present with multisystem involvement before typical skin lesions appear 5.

Elderly: More common in older adults, predominantly affecting men 1.

Comorbidities: Management must consider concurrent conditions like focal glomerulosclerosis requiring immunosuppressive therapy 4.

Key Recommendations

Biopsy for Definitive Diagnosis: Essential for confirming KS and assessing disease stage 1.

Tailored Treatment Based on Extent and Underlying Condition: Use chemotherapy like vinblastine for disseminated disease and radiation for localized cutaneous lesions 4 6.

Monitor for Multisystem Involvement: Especially in pediatric transplant recipients, where KS may present atypically 5.

Address Immunosuppression: Manage underlying immunosuppression carefully to prevent KS progression 1 4.

Supportive Care for Complications: Focus on managing complications such as airway obstruction and pain 2 3.

(Evidence: Strong 4 6, Moderate 1 5, Weak 2 3)

References

1 Kamyab K, Ehsani AH, Azizpour A, Mehdizad Z, Aryanian Z, Goodarzi A et al.. Demographic and histopathologic study of Kaposi's sarcoma in a dermatology clinic in the years of 2006 to 2011. Acta medica Iranica 2014. link 2 Torretta S, Gaffuri M, Recalcati S, Marzano AV, Cantarella G, Iofrida E et al.. Pharyngolaryngeal location of Kaposi's sarcoma with airway obstruction in an HIV-negative patient. Tumori 2013. link 3 Daniel J, Shaw A. Septic illness and Kaposi's sarcoma. International journal of STD & AIDS 2007. link 4 Zerbi S, Saruggia M, Brambilla L, Lodeville D, Buccianti G. Kaposi's sarcoma in a patient with focal glomerulosclerosis. Journal of nephrology 2001. link 5 Yokois NU, Perlman EJ, Colombani P, Wise B, Schwarz KB. Kaposi's sarcoma presenting as a protracted multisystem illness in an adolescent liver transplant recipient. Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 1997. link 6 Conill C, Alsina M, Verger E, Henríquez I. Radiation therapy in AIDS-related cutaneous Kaposi's sarcoma. Dermatology (Basel, Switzerland) 1997. link 7 Sternbach G, Varon J. Moritz Kaposi: idiopathic pigmented sarcoma of the skin. The Journal of emergency medicine 1995. link00077-n) 8 Rutgers JL, Wieczorek R, Bonetti F, Kaplan KL, Posnett DN, Friedman-Kien AE et al.. The expression of endothelial cell surface antigens by AIDS-associated Kaposi's sarcoma. Evidence for a vascular endothelial cell origin. The American journal of pathology 1986. link 9 Beckstead JH, Wood GS, Fletcher V. Evidence for the origin of Kaposi's sarcoma from lymphatic endothelium. The American journal of pathology 1985. link 10 Finlay AY, Marks R. Familial Kaposi's sarcoma. The British journal of dermatology 1979. link

Kaposi's sarcoma (clinical)